Citigroup Inc Decibel Therapeutics, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$3.82 - $5.61 $7,173 - $10,535	-1,878 Reduced 86.58%	291 $1,000
Q2 2022 Aug 10, 2022	BUY	$1.85 - $4.21 $3,030 - $6,895	1,638 Added 308.47%	2,169 $9,000
Q1 2022 May 12, 2022	SELL	$2.83 - $5.03 $622 - $1,106	-220 Reduced 29.29%	531 $2,000
Q4 2021 Feb 10, 2022	BUY	$4.57 - $8.58 $3,432 - $6,443	751 New	751 $3,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.